Use of trimebutine for treating pain
OwnerAgnes Grouhel, Gilles Brunelle +2inventors
InventorsAgnes Grouhel, Gilles Brunelle, Francois Roman, Jacques Hamon
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of trimebutine [2-dimethylamino-2-phenylbutyl-3,4,5-trimethoxy-benzoate hydrogen maleate] or its corresponding stereoisomers for the preparation of a medicament to prevent and/or treat inflammatory somatic pain as well as chronic pain.
Claims17
Use of Trimebutine [2-dimethylamino-2-phenylbutyl-3,4,5-trimethoxy-benzoate hydrogen maleate], at least one of its metabolites or at least one of its sereoisomers for the preparation of a medicament to prevent and/or treat somatic pain other than visceral pain.
Use of Trimebutine [2-dimethylamino-2-phenylbutyl-3,4,5-trimethoxy-benzoate hydrogen maleate], at least one of its metabolites, or at least one of its sereoisomers for the preparation of a medicament to prevent and/or treat chronic pain or inflammatory somatic pain other than visceral pain.
Use according to any one of the preceding claims to prevent and/or treat hyperalgesia
Use according to any one of the preceding claims to prevent and/or treat pain related to central hypersensitivity conditions, chronic pain or inflammatory somatic pain.
Use according to any one of the preceding claims to prevent and/or treat neurological pain.
Use according to any one of the preceding claims to prevent and/or treat arthritis.
Use according to any one of the preceding claims to prevent and/or treat osteo-traumatic pain.
Use according to any one of the preceding claims to prevent and/or treat back pain.
Use according to any one of the preceding claims to prevent and/or treat cancer pain.
Use according to any one of the preceding claims to prevent and/or treat HIV related pain.
Use according to any one of the preceding claims to prevent and/or treat neuralgias including post-herpetic neuralgia.
Use according to any one of the preceding claims to prevent and/or treat vascular pain.
Method for preventing or treating somatic pain other than visceral pain comprising administering trimebutine, at least one of its metabolites, or at least one of its sereoisomers to a patient in need thereof.
Method for preventing or treating chronic pain other than visceral pain comprising administering to a patient in need thereof.
Dependencies are inferred from the claim text.